騰景科技(688195.SH):與部分AR眼鏡整機廠商建立了合作關係
格隆匯2月10日丨騰景科技(688195.SH)披露投資者關係活動記錄表顯示,在AR領域,公司專注於底層光學技術的開發及應用,在幾何光波導、衍射光波導、AR光機模組等方面均有佈局。公司與部分AR眼鏡整機廠商建立了合作關係,已有幾何光波導片等少量精密光學元組件產品應用於AR眼鏡光學系統中,AR近眼顯示光機模組和納米壓印衍射波導片初步完成產品開發並持續迭代。
隨着人工智能、光學顯示、計算能力以及感知交互技術的不斷進步,AR行業正迎來加速發展期。AR產業潛力大、技術跨度大、應用空間廣,並且隨着技術與行業應用的融合逐步加速,AR設備滲透率也將進一步提升。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.